Maine § 22 §8732 Drug price notifications and disclosures

Maine Statutes

§ 22 §8732 — Drug price notifications and disclosures

Maine § 22 §8732

Title 22HEALTH AND WELFARE

Part 3DRUG ABUSE

Ch. 1683MAINE HEALTH DATA ORGANIZATION

This text of Maine § 22 §8732 (Drug price notifications and disclosures) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 22, § 22 §8732 (2026).

Text

1.Notifications by manufacturers. 1-A. Public notice of substantial drug price change or introduction. No later than January 30, 2022 and annually thereafter, the organization shall produce and post on its publicly accessible website a list of prescription drugs for which the manufacturer has during the prior calendar year:

2.Disclosures by manufacturers, wholesale drug distributors and pharmacy benefits managers. The following disclosures apply to manufacturers, wholesale drug distributors and pharmacy benefits managers.

3.Notification by manufacturers of wholesale acquisition cost for insulin. No later than February 15th of each year, a manufacturer of insulin shall notify the organization of the wholesale acquisition cost per pricing unit for the insulin produced by the manufacturer

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Notifications by manufacturers.
1-A.
Public notice of substantial drug price change or introduction.
No later than January 30, 2022 and annually thereafter, the organization shall produce and post on its publicly accessible website a list of prescription drugs for which the manufacturer has during the prior calendar year:
2.
Disclosures by manufacturers, wholesale drug distributors and pharmacy benefits managers.
The following disclosures apply to manufacturers, wholesale drug distributors and pharmacy benefits managers.
3.
Notification by manufacturers of wholesale acquisition cost for insulin.
No later than February 15th of each year, a manufacturer of insulin shall notify the organization of the wholesale acquisition cost per pricing unit for the insulin produced by the manufacturer in each category of insulin.